Microneedling Consent Form Template (Incl. RF & PRP)

Not medical or legal advice. This page describes how microneedling consent forms are commonly organized and the ground they usually cover. It sets no clinical standard, does not recommend settings, and does not state any state's law. Your medical director must approve every consent form before patients sign it, and the form should be reviewed by healthcare counsel familiar with your state's consent, delegation and records rules.

Ask a med spa owner whether they have a microneedling consent form and the answer is almost always yes. Ask when it was last compared with the device actually in the treatment room, the serums actually applied, and the add-ons actually on the price list, and the answer gets vaguer. Microneedling menus change quickly. A practice that bought a manual pen a few years ago may now run an automated pen, an RF microneedling platform, and a PRP add-on, while the form in the intake packet still describes the first of those and nothing else.

This guide covers the consent conversation and the signed form, who should hold the conversation, the elements a microneedling form needs, how RF and PRP change it, whether a free PDF is usable, and how to document and refresh consent over a series. It does not give needle depths, energy settings, session spacing or recovery timelines; those belong in your clinical protocol, set by your medical director against the manufacturer's instructions.

Is a Microneedling Consent Form the Same as Informed Consent?

No. Informed consent is the discussion in which a qualified practitioner explains the treatment, its alternatives and its risks, answers the patient's questions, and confirms the patient wants to go ahead; the signed form is the evidence that this discussion took place. You need both, and neither substitutes for the other.

The distinction sounds academic until something goes wrong. A reviewer looking at a microneedling complaint will ask who spoke to the patient, what they said, whether the patient had a real opportunity to ask questions, and whether the risks discussed were the risks of the treatment the patient actually received. The form answers part of that. The chart note, the practitioner's account, and the practice's written process answer the rest. A form handed over at the front desk, signed in the waiting room, and never discussed proves that the patient held a pen. It does not prove the patient understood that the treatment could leave them with pigment change.

What the conversation covers that the form cannot

The form is a fixed document. The conversation is where the practitioner adapts the general risks to the specific patient in front of them. A patient with a history of cold sores needs to hear what that history means for this treatment. A patient with a deeper skin tone needs a frank discussion of pigment risk. A patient who has asked for "the one with the blood" needs to understand that a blood draw is part of the visit. None of that tailoring happens on paper unless the practitioner writes it down.

The strongest records therefore pair a well-built form with a short practitioner note, written at the visit: who led the conversation, that the patient's questions were answered, and any patient-specific risk factors that were discussed.

What a signed form is able to prove

At its best, a microneedling form proves that this patient, on this date, before treatment, was told about the risks of this modality with these add-ons, and agreed. An undated form, a standard-microneedling form used for an RF session, or a form signed after treatment each breaks that chain. Specificity, not length, is what makes the form useful as evidence.

Who Should Obtain Consent for Microneedling?

Consent for microneedling belongs with a clinician able to field medical questions about it: ideally the person who examined the patient and ordered the treatment, or the person who will perform it. It should not be delegated to a front-desk coordinator, a sales consultant, or anyone who could not explain what the risks mean or how the practice would respond to them.

Who is allowed to perform microneedling at all is a separate question, and the answer varies by state, by credential and by the depth and modality involved. We cover it in our guide to who can perform microneedling and map the state differences in our microneedling laws by state pillar.

For the consent form itself, the practical point is honesty about roles. Many practices separate the examining provider from the treating practitioner. Where that happens, the form should have one line for whoever led the consent conversation and a separate line for the practitioner who performed the treatment, each with a printed name and credential. If the form implies that the treating practitioner examined the patient when someone else did, or the reverse, it creates an inconsistency with the chart that a reviewer will notice quickly. The good-faith examination itself, and who may perform it, is covered in our good-faith exam guide.

What Must a Microneedling Consent Form Include?

A microneedling consent form must identify the procedure and device, record that depth and settings are chosen by the practitioner, describe downtime and common effects in general terms, and name the main risks individually. It should carry screening questions for practitioner review, photography consent, aftercare and warning signs, and dated signatures from the patient and the practitioner.

Use this list to audit your current form. Each item is explained below, followed by the extra disclosures that RF microneedling and PRP require.

1. Procedure and device type — standard microneedling, RF microneedling, or microneedling with PRP, and the device or device category used.
2. Depth and settings set by the practitioner — a statement that the practitioner selects depth and settings for each area under the practice's protocol, recorded in the treatment note rather than printed as fixed numbers on the form.
3. Treatment areas — each area listed individually.
4. Expected downtime — described in general terms, with a note that it varies between people and with the treatment chosen.
5. Common effects — the expected, usually temporary reactions.
6. Risks to disclose — infection; scarring; hyperpigmentation and other pigment change, especially in darker skin types; herpes simplex (cold sore) reactivation; and allergic or irritant reaction to topicals, including numbing cream and anything applied to the treated skin.
7. Screening questions — active acne or skin infection, isotretinoin history, keloid or raised-scar tendency, pregnancy or breastfeeding, and anticoagulant or blood-thinning medication, each answered by the patient and reviewed by the practitioner.
8. Alternatives and expectations — other treatments, no treatment, and the fact that results vary and a series may be recommended.
9. Photography consent — clinical photographs for the record, with marketing use handled separately.
10. Aftercare and warning signs — confirmation that written aftercare was given, plus the symptoms that mean the patient should call.
11. Signatures and date — patient attestation, signature and date, practitioner name, credential and signature, and the form version.

Procedure and device type

"Microneedling" covers a wide range of treatments. A manual roller, an automated pen, and an RF microneedling platform deliver very different injuries to the skin, and the risks that matter shift between them. The form should say which modality the patient is receiving and, ideally, identify the device or at least the device category. If the practice runs more than one device, leave a place to record which one is used at the visit, or use a separate form for each modality.

Depth and settings set by the practitioner

Patients increasingly arrive knowing that microneedling can be set deeper or shallower and ask for "the deeper one" because they have seen it online. The consent form should explain, in a sentence, that the practitioner chooses the depth and device settings for each treatment area based on the patient's skin, goals and the practice's protocol, and that the settings used will be recorded in the patient's treatment record. That statement does two things. It tells the patient that settings are a clinical decision rather than a menu choice, and it points the reviewer to where the actual numbers live.

We recommend against printing specific depths or energy levels on the consent form itself. Numbers on a patient-facing form go out of date when a device or protocol changes, they invite arguments that a different setting was used than the one "agreed," and in some states the depth involved is part of the scope question, which is better handled in your protocol and delegation records than in a document the patient signs. If your medical director prefers the form to show the depth range the practice works within, as some consent checklists suggest, take that range from the approved protocol and update the form whenever the protocol changes. Your clinical protocol, signed by your medical director, is where settings belong. Our RF microneedling protocol guide describes the parameter documentation an RF SOP should require.

Treatment areas

List the face, neck, chest, scars, stretch marks or other areas being treated individually. "As discussed" is not a treatment area. Areas matter for consent because some carry different considerations: thinner skin, proximity to the eyes, or a scar the patient hopes will improve. If the practitioner and patient agree during the appointment to add an area, update the form and have both initial the change before treating it. A treatment note that lists more areas than the consent form is an easy gap for anyone reviewing the chart to find.

Expected downtime, in general terms

Downtime is the part of the form patients read most closely, because it decides whether they can go to work or attend an event. Describe it honestly and without numbers: that the skin is usually red and may be swollen afterwards, that some patients see dryness, flaking or light crusting as the skin recovers, that recovery tends to be longer after more intensive treatment and after RF, and that individual recovery varies. If your practice gives patients a specific expectation, put it in the aftercare handout approved by your medical director, where it can be updated with the protocol, not on the consent form.

Common effects the patient should expect

Spell out what normal healing looks like so a patient does not mistake it for injury: redness, a sunburn-like feeling, swelling, pinpoint bleeding during or just after treatment, tenderness, dryness and flaking, and small marks along the treated skin. For RF treatment, add warmth and a grid of tiny marks from the needle array. Say that these normally fade as the skin recovers.

Risks the form must disclose

This is the section that does the work in a dispute, and each risk should get its own line in everyday language, with a brief note on what it means for the patient. At a minimum the form should name:

• Infection. Microneedling creates many small openings in the skin. Bacteria, viruses or fungi can enter them, particularly if aftercare is not followed or contaminated products are applied. Infection may need treatment and can affect the final result.
• Scarring. Although the treatment is often used to improve scars, it can also cause them, including raised or thickened scars in people prone to them, and marks that follow the path of the needles.
• Hyperpigmentation and other pigment change. Treated skin can darken after the inflammation of treatment, and less commonly lighten. The form should say plainly that the risk of darkening is higher in darker skin types, that pigment change can last a long time, and that sun exposure after treatment makes it more likely.
• Herpes simplex reactivation. Patients who have had cold sores can have an outbreak triggered by treatment around the mouth or elsewhere on the face. The form should ask about cold-sore history and record that the practitioner discussed it.
• Allergic or irritant reaction to topicals. Numbing cream, serums, growth-factor products and other topicals placed on or into treated skin can cause irritation, rash or allergic reaction. Products not intended to be delivered into the skin have been associated with granuloma formation, which is one reason the form should name what is applied.

Depending on your devices, add-ons and patients, other risks may belong here, for example bruising, prolonged redness, acne flares, temporary textural change, or an unsatisfactory or uneven result. The device labeling and your protocol are the starting points for that list.

Do not soften the risks with reassurance such as "very rare" or "minimal risk"; you almost certainly have no reliable figure to support it. Say plainly that the risk exists, may be lasting, and can occur even when treatment is performed correctly. Our laser and peel complications guide covers pigment change, burns and scarring from the clinical-operations side.

Screening questions for the practitioner

The consent form, or the intake form it references, should ask the patient a set of screening questions and leave room for the practitioner to record that the answers were reviewed. The questions are prompts for clinical judgement, not automatic rules. Whether a "yes" means proceed, adjust, postpone or decline is the practitioner's decision under the medical director's protocol, and the form should say so rather than presenting any answer as an automatic disqualification. Typical questions include:

• Do you have active acne, a rash, an open wound or any skin infection in the area to be treated?
• Have you ever taken isotretinoin, and if so, when did you last take it?
• Do you form keloids or raised scars after cuts, piercings or surgery?
• Are you pregnant, trying to become pregnant, or breastfeeding?
• Do you take anticoagulants, blood thinners or other medicines or supplements that affect bleeding?
• Have you had cold sores or other herpes outbreaks on your face?
• Do you have any allergies, including to numbing creams, skincare ingredients or metals?

Further questions may be added by your medical director, for example about conditions that affect healing or the immune system, recent sun exposure or tanning, recent procedures in the area, or, for RF devices, implanted electronic devices and metal in the treatment area. The patient's answers should be signed and dated, and the practitioner should initial that they were reviewed before treatment. If an answer led to a change in plan, the treatment note should say what changed and why.

Do not turn the screening list into clinical instructions on the patient form, such as fixed waiting periods after a medication; printed rules can conflict with the protocol your medical director actually approves. Keep questions on the form and rules in the protocol. Our intake form template guide covers how to collect and update the health history the screening relies on.

Alternatives and realistic expectations

Informed consent requires that the patient knew they had options. For microneedling those usually include topical skincare, chemical peels, laser or other energy-based treatments, injectable options for some concerns, and doing nothing. The form does not have to argue for or against each one; it needs to record that alternatives were discussed. It should also say that results vary, that improvement is usually gradual rather than immediate, that more than one session may be recommended, and that the practice cannot guarantee a specific cosmetic outcome. Expectation disputes are among the most common complaints after skin treatments, and the signed form is where those expectations were written down.

Photography consent

Standardized before-and-after photographs are part of the clinical record, and after a skin treatment they are often the most persuasive evidence of what the skin looked like before and after. The form should include consent to clinical photography for the medical record. Using those images on a website, social media or in a brochure is a different decision. It needs its own written, revocable authorization, separate from the treatment consent, so that a patient's agreement to be photographed for their chart is never mistaken for agreement to appear in an advertisement. Our before-and-after photo rules guide covers the marketing side.

Aftercare and warning signs

Aftercare gets one line on the consent itself: a statement that the patient was given the written handout and went through it with the practitioner. The detailed instructions are best kept on a separate handout, which can be updated as the protocol changes; our aftercare instructions template guide sets out what a microneedling handout should cover, and RF microneedling should have its own handout rather than share one.

Warning signs are different. They are part of the risk disclosure, so they need to appear on the consent form too. Tell the patient to call if pain, redness or swelling is getting worse rather than better, if the skin becomes hot, oozes, develops pus-filled spots or crusts that spread, if they develop a fever, if blisters or a cold-sore outbreak appear, if a rash or hives develop, or if an area looks burned or changes color. Severe swelling of the face or lips or any difficulty breathing should be treated as an emergency. Print a number someone actually answers after hours, or spell out what the patient should do when nobody at the practice is reachable.

Signatures, date and practitioner identity

The signature block should include an attestation in plain, first-person language: that the patient has read the form, had the opportunity to ask questions, had those questions answered, has given accurate health information, and agrees to proceed. The patient signs and dates before treatment. The practitioner prints their name and credential and signs to confirm they held the discussion. Where the examining and treating practitioners differ, both should be identified. Add the form version number in the footer so the record shows exactly which wording the patient saw. Whether a witness is required is a question for your counsel and your state's rules; where a witness is used, it must be a person who was present when the patient signed.

Many practices also ask the patient to initial beside each named risk. Initials are no substitute for the conversation, yet they leave little room to claim a named risk was skipped.

RF microneedling: what the add-on changes

Radiofrequency microneedling delivers heat into the skin through the needles, so the consent form needs everything a standard microneedling form contains plus a thermal-injury disclosure. The form should say that the device uses radiofrequency energy and name the heat-related risks plainly: burns, including burns that may blister or scar; prolonged redness and swelling; pigment change, which heat can make more likely in darker skin; and, consistent with the adverse events described in the FDA's 2025 safety communication on RF microneedling devices that we summarize in our microneedling scope guide, fat loss, nerve injury and disfigurement. A form written before that communication that omits those last risks should be reviewed and re-dated.

RF screening also adds questions that mechanical microneedling does not need, such as implanted electronic devices and metal hardware near the treatment area. Those belong in the screening section as questions for the practitioner, consistent with how your protocol handles them. Settings, depths, passes and anesthetic practice are protocol matters, and the protocol side of RF microneedling, including contraindication screening and parameter documentation, is set out in our RF microneedling protocol guide. Your form needs to agree with that protocol without trying to reproduce it.

Many practices use a separate RF consent form rather than an RF checkbox on the standard form. Either works if the RF disclosure is distinct and the form signed matches the device used.

PRP: a blood draw and the patient's own plasma

Adding platelet-rich plasma turns one procedure into several. The patient has blood drawn, the blood is processed into a concentrate, and the patient's own plasma is applied to or placed into the treated skin. The consent form should describe each step in plain language and disclose the elements that standard microneedling does not involve: the venipuncture and its own risks, such as bruising, discomfort, lightheadedness or fainting, and infection at the draw site; the handling of the patient's blood and the controls the practice uses to keep it identified and uncontaminated; and the application of the concentrate to the treated skin.

The form should not make claims about what PRP achieves. State that adding PRP is the patient's choice, that results vary, that no particular improvement is promised, and that its use in aesthetic treatment is off-label use of the processing device. Many practices use a separate PRP consent or a clearly separate PRP section with its own signature, so that the patient's agreement to the blood draw is recorded explicitly. Who may draw blood and apply the product is a scope question covered in our PRP and PRF compliance guide, which also covers the blood-handling and documentation side.

If your practice offers other "boosters" applied to microneedled skin, each one needs the same treatment: named on the form, with its own disclosure. Be particularly careful with products marketed as exosomes, which raise separate regulatory questions covered in our exosomes guide. A consent form cannot make an unapproved product lawful to use.

Is There a Free Microneedling Consent Form PDF?

Yes, free microneedling consent forms are easy to find, but none of them is ready to use as downloaded. A free PDF is a starting point only: it has to be matched to your device, your add-ons and your state's scope rules, rewritten in your practice's words, and approved by your medical director before a patient signs it.

Downloaded templates fail in predictable ways. Many were written for a single device and describe it by brand. Many print fixed depths or recovery timelines that do not match your protocol. Some fold RF and PRP into one line, or omit them entirely. Some were written for a state with different rules on who may perform the treatment and so describe a supervision arrangement your practice does not use. Others include clinical instructions, such as medication waiting periods, that your medical director has never reviewed. And very few address topicals applied to treated skin, which is where some of the more serious reactions come from.

If you start from a free template, use it as a checklist rather than a finished document: compare it with the elements on this page, delete what does not reflect how you treat, add the disclosures your device and add-ons need, and record your medical director's approval and the date the form went into use.

How Should Topicals Applied During Microneedling Appear on the Form?

Every product applied to microneedled skin should be named on the form or in a referenced treatment record, along with the risk of reaction to it. The channels created by the needles let products reach deeper layers of skin than they would through intact skin, so a product that is harmless on the surface may behave differently once the barrier is open.

That applies to the numbing cream applied before treatment, the glide or serum used during it, and anything applied immediately afterwards. The form should say that topical products will be used, identify them or point to the treatment record where they are identified, and disclose the possibility of irritation, allergic reaction and, for products not intended for delivery into the skin, granuloma formation. If a patient brings their own product and asks for it to be applied, the practice's protocol should say whether that is permitted; if it is not, the form can say so.

How Should You Document and Store Microneedling Consent?

A microneedling consent is evidence only in context. If nobody can say which visit, device and settings a signature relates to, it carries little weight; a plain form embedded in a chart where every entry agrees carries a great deal.

Tying the consent to each treatment note

For every session, the chart should hold the signed consent for that visit or a reference to the current signed consent, the screening answers and the practitioner's review of them, the good-faith exam or treatment order, the device used, the settings and areas treated, any topicals applied, any PRP draw and its handling, pre-treatment photographs, and confirmation that aftercare was given. The modality and add-ons on the consent should match those in the treatment note. If they do not, a note should explain the change and record that the patient agreed to it beforehand. Recording single-use needle cartridges and device identifiers supports traceability if a device or supply problem emerges later.

How long to keep signed microneedling consent forms

A signed microneedling consent is a medical record, so it is kept for as long as the chart it belongs to. That period is set by state law and other obligations, and minors are often treated differently from adults; there is no microneedling-specific clock. Our medical records retention guide explains how to work out the period for your practice.

Archive every retired version of the template, not only the signed forms. When an old patient raises a complaint, what matters is the wording in force on the day they signed. A simple version log recording when each version took effect, who approved it and what changed answers that question in minutes rather than days.

Electronic signatures

Tablet and portal consent is now common for microneedling, and it can be a stronger record than paper if the system is set up well. The platform should record who signed, when, from which device or session, and exactly which version of the form they saw. It should preserve the signed text even after the template is edited, so that a later change does not silently rewrite past consents. The risk section should be on screen before signing is possible, and it should capture the practitioner's signature as well as the patient's.

Watch for the modality mismatch: a patient books standard microneedling online, signs the standard form, and is upgraded to RF or PRP at the visit without a new form. Make the correct form a precondition of the treatment actually performed, and if patients sign before the visit, the practitioner still holds the discussion at the visit and records it before treatment. Confirm with counsel that your platform meets your state's requirements for electronic records and signatures.

When does a microneedling patient need to re-consent?

Microneedling is usually sold as a series, which raises the question of whether one signature covers every session. The safer answer is that consent should be refreshed whenever something material changes, and the most common material changes are:

• A change of device or modality, especially a move from standard microneedling to RF, because the risk disclosure changes.
• A new add-on, such as PRP or a different topical product, which brings its own disclosures.
• A new treatment area not covered by the original form.
• A change in the patient's health, such as new medication, pregnancy, a new skin condition or a new history of cold sores, revealed by updated screening.
• A complication or unexpected reaction at an earlier session, which should prompt a fresh discussion before treatment continues.
• A new version of the form, so returning patients are on today's wording.
• A change of treating practitioner, when the patient's agreement was to a named person.

Some practices take a series consent with a short visit-level confirmation that screening was updated and nothing material changed; others take a full consent every session. Either can be defensible. What is hard to defend is no written policy, or one applied inconsistently.

What Should a Microneedling Consent Form Template Look Like?

Good microneedling templates follow the order in which a patient thinks about the treatment, and they let an auditor locate any element at a glance. Treat the table below as a skeleton for section headings only; the wording itself comes from your medical director and counsel.

Do not paste a manufacturer's patient brochure in as your consent. Draw the required disclosures from the device labeling, then write the form in your own plain language for your medical director to approve.

Our med spa consent forms guide covers the full set of forms a practice needs and how the microneedling form fits alongside the general consent to treat and the other procedure-specific forms.

Which Microneedling Consent Mistakes Cause the Most Trouble?

Microneedling complaints that reach a licensing board, an insurer or a lawyer tend to expose the same few weaknesses. Most are not about missing paperwork; they are about paperwork that does not match what happened.

One skin-treatment form for everything

A general "skin services consent" that covers facials, peels, microneedling and lasers in one paragraph tends to describe none of them adequately. The pigment risk is mentioned in passing, the topicals are not mentioned at all, and RF heat is absent. Microneedling deserves its own form, and RF and PRP deserve their own clearly separate disclosures.

The device or add-on changed but the form did not

A practice that added an RF platform or a PRP service without revising its microneedling consent has patients signing a form that does not describe their treatment. This is the most common and most avoidable gap. Every time a device, add-on or topical is introduced, the consent form should be reviewed before the first patient is treated with it.

Pigment risk understated for darker skin

A form that lists "temporary discoloration" without saying that darker skin carries a higher risk of lasting pigment change is a weak disclosure for exactly the patients who most need it. Name the risk clearly, and make sure the practitioner discusses it with patients for whom it is most relevant and records that discussion.

No warning signs or after-hours contact

When a patient with a developing infection waited because they assumed worsening redness was normal, or could not reach anyone over a weekend, a form with no warning signs and no reachable contact ends up as an exhibit for the patient, not the practice. Our infection control protocol guide covers the practice-side controls that sit behind those warning signs.

How Does the Consent Form Fit With Your Microneedling SOPs?

The consent form tells the patient about risks that the practice's protocols are designed to manage, so the two must agree. If your microneedling SOP screens for isotretinoin history, the form should ask about it. If your RF protocol treats implanted devices as a screening issue, the form should ask about them. If your protocol describes a response to suspected infection or a cold-sore outbreak, the form should tell the patient to report those symptoms. If the form promises an after-hours number, there must be someone answering it.

It also helps to compare the microneedling form with your other procedure-specific forms. The same attestation, photography and signature structure can be shared across them, which makes training and review easier, while the procedure, risk and screening sections stay specific to each treatment. Our neurotoxin consent guide and dermal filler consent form guide show how the same shared structure carries different disclosures for injectables.

Key Takeaways

• The discussion belongs to a clinically qualified practitioner, and the form names both the person who held it and the person who treated.
• Name the modality and device, and say whether RF energy or PRP is involved.
• State that depth and settings are set by the practitioner under protocol; record the numbers in the treatment note, not on the form.
• Name the risks individually: infection, scarring, pigment change with emphasis on darker skin, cold-sore reactivation, and reactions to topicals.
• Ask screening questions and have the practitioner review them; keep clinical rules in the protocol.
• Give RF a thermal-injury disclosure and PRP a blood-draw disclosure, and make no efficacy claims for PRP.
• Separate chart photography from marketing use, and print the warning signs and a reachable after-hours number on the form.
• Re-consent when the device, add-on, area, practitioner or patient's health changes, and keep version history.
• Treat any free PDF as raw material: the medical director signs off the final version and healthcare counsel reviews it.

This page offers general information on organizing and maintaining microneedling consent documents. It is neither medical nor legal advice, sets no clinical standard and states no state's law. Before any patient signs, your medical director must approve the form and healthcare counsel must review it.